China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE: 000999)

China Resources Sanjiu Medical & Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,143	6,771	3,150	3,065	3,824	3,091
Trading Asset Securities	2,704	1,456	-	1,219	200.18	-
Cash & Short-Term Investments	8,847	8,227	3,150	4,284	4,024	3,091
Cash Growth	21.26%	161.19%	-26.48%	6.45%	30.18%	24.84%
Accounts Receivable	7,958	7,946	5,644	5,419	4,807	4,897
Other Receivables	304.5	56.56	14.02	79.28	49.05	779.73
Receivables	8,262	8,003	5,658	5,498	4,856	6,022
Inventory	5,057	5,112	2,499	2,369	1,762	1,458
Other Current Assets	982.55	1,180	681.97	527.57	283.32	232.29
Total Current Assets	23,148	22,522	11,988	12,679	10,925	10,804
Property, Plant & Equipment	6,491	6,614	4,816	4,263	3,767	3,612
Long-Term Investments	758.76	643.12	2,913	238.69	176.35	821.82
Goodwill	5,124	5,124	3,995	4,060	4,105	3,354
Other Intangible Assets	3,375	3,457	2,369	2,297	2,178	1,812
Long-Term Deferred Tax Assets	584.15	626.81	324.5	242.1	150.3	125.82
Long-Term Deferred Charges	825.5	788.34	509.29	467.08	522.68	383.62
Other Long-Term Assets	463.51	373.28	207.33	295.37	185.78	488.78
Total Assets	40,770	40,148	27,123	24,542	22,010	21,402
Accounts Payable	3,112	3,097	1,795	1,499	1,118	1,048
Accrued Expenses	1,240	4,569	3,666	3,215	3,547	3,529
Short-Term Debt	821.61	885.65	168.5	90.04	25	30
Current Portion of Long-Term Debt	403.95	93.42	10.76	-	-	-
Current Portion of Leases	-	78.6	50.12	45.47	-	-
Current Income Taxes Payable	529.39	254.47	110.6	168.15	181.61	110.63
Current Unearned Revenue	1,461	1,650	1,012	1,476	980.14	797.86
Other Current Liabilities	4,715	2,318	1,859	1,453	1,444	1,385
Total Current Liabilities	12,283	12,947	8,673	7,947	7,295	6,899
Long-Term Debt	1,382	1,821	50.22	7.97	-	895.78
Long-Term Leases	82.31	119.51	105.82	88.71	-	-
Long-Term Unearned Revenue	455.71	455.5	423.19	395.13	346.4	355.35
Long-Term Deferred Tax Liabilities	334.21	340.79	217.75	198.88	195.42	140.59
Other Long-Term Liabilities	168.11	114.64	36.8	40.19	113.81	32.52
Total Liabilities	14,706	15,887	9,589	8,767	7,951	8,324
Common Stock	1,284	988.18	988.35	978.9	978.9	978.9
Additional Paid-In Capital	1,615	1,878	1,797	1,644	1,636	1,844
Retained Earnings	17,639	16,162	14,297	12,690	11,117	9,941
Treasury Stock	-76.98	-131.98	-143.57	-	-	-
Comprehensive Income & Other	70.83	71.26	70.59	0.22	-4.96	-3.55
Total Common Equity	20,533	18,967	17,010	15,313	13,727	12,760
Minority Interest	5,531	5,295	523.78	461.28	331.95	318.03
Shareholders' Equity	26,064	24,262	17,533	15,774	14,059	13,078
Total Liabilities & Equity	40,770	40,148	27,123	24,542	22,010	21,402
Total Debt	2,690	2,998	385.42	232.18	25	925.78
Net Cash (Debt)	6,157	5,229	2,764	4,052	3,999	2,166
Net Cash Growth	40.51%	89.15%	-31.78%	1.31%	84.68%	11.57%
Net Cash Per Share	4.82	4.09	2.15	3.18	3.14	1.70
Filing Date Shares Outstanding	1,284	1,285	1,285	1,273	1,273	1,273
Total Common Shares Outstanding	1,284	1,285	1,285	1,273	1,273	1,273
Working Capital	10,865	9,575	3,316	4,732	3,630	3,905
Book Value Per Share	15.99	14.76	13.24	12.03	10.79	10.03
Tangible Book Value	12,034	10,387	10,645	8,956	7,445	7,595
Tangible Book Value Per Share	9.37	8.09	8.29	7.04	5.85	5.97
Buildings	-	5,122	3,459	3,419	3,170	2,971
Machinery	-	4,544	3,621	3,361	3,053	2,842
Construction In Progress	-	537.8	946.09	407.7	287.54	390.3

Source: S&P Capital IQ. Standard template. Financial Sources.